At Confmeets Journals, the Editorial Board serves as the cornerstone of academic integrity and excellence. Comprising distinguished scholars and professionals across various disciplines, the board ensures that each manuscript undergoes a rigorous peer-review process aligned with the journal's mission.
Our board members are committed to upholding the integrity, quality, and ethical standards of scholarly publishing. They collaborate closely with authors, reviewers, and the Confmeets editorial team to uphold ethical practices, promotes transparency, and guarantee that every published article contributes meaningfully to the advancement of knowledge in its field.
Department: Department of Biological Sciences and Preventive Medicine
Affiliation: Biohellenika Biotechnology Company, Greece
Designation: Professor
Email:Country: Greece
George Koliakos was born in Thessaloniki, Greece in 1956. He earned his MD in 1979 and his PhD in Biochemistry in 1983 from the Medical School of Aristotle University. He specialized in Nuclear Medicine between 1983 and 1987. His academic journey includes postdoctoral research at the University of Minnesota (1987–1989) and a visiting professorship at the University of Miami (1993). From 1989 to 2023, he served as a faculty member at the Medical School of Aristotle University, where he was Professor of Biochemistry and is now Professor Emeritus. He directed the Joint Postgraduate Program in “Stem Cell and Regenerative Medicine” in collaboration with Democritus University of Thrace (2019–2023). In addition to serving as Editor of the Aristotle Biomedical Journal and President of the Hellenic Society for Regenerative Medicine Research, he held several key academic leadership roles, including Director of the Laboratory of Clinical Biochemistry at AHEPA University Hospital and Director of the Laboratory of Biological Chemistry at Aristotle University. He also led the Department of Biological Sciences and Preventive Medicine across multiple terms. Outside academia, he co-founded Hippocrates Diagnostic Center (1991–2006), served as CEO of the Hellenic National Research Center Stem Cell Bank (2007–2014), and is currently the Founder, President, and CEO of Biohellenika Biotechnology Company. A prolific researcher, Dr. Koliakos has co-authored over 200 peer-reviewed publications with more than 6,000 citations, holds eight patents, and has been principal investigator on 17 national research grants.
Affiliation: Project Instructor, Keio University School of Medicine, Tokyo
Department: Department of Ophthalmology
Designation: Project Instructor
Email:Country: Japan
Dr. Deokho Lee is an ophthalmic medical researcher specializing in hypoxia/ischemia-related vision loss, retinal degeneration, and neovascularization in diseases such as diabetic retinopathy, glaucoma, and age-related macular degeneration. He currently serves as a Project Instructor at Keio University School of Medicine and as a Research Professor at The Korean Institute of Nutrition, Hallym University. His expertise includes ERG, OCT, molecular biology, and cell biology, with a strong focus on developing novel therapeutic strategies and nutritional interventions for ocular diseases.
Affiliation: Health Science, Abu Dhabi University, Kansas
Department: Department of Health Sciences
Designation: Director
Email:Country: United Arab Emirates
Massimo Piracci completed his MBBS from Roma Tor Vergata, Italy in 1992 and subsequently received his MD in Orthopedic and Traumatology from the same University in 1999. He was trained in Orthopedic Surgery in Roma Saint Eugenio Hospital and in Latina Santa Maria Goretti Hospital. From 2003 was HOD in Orthopedic and Traumatology Department in Roma Clinic Annunziatella where he did more than 10.000 surgery. He was also Football Referee for FIGC for 15 years and also external orthopedic consultant for different football team. From 2014 in UAE. He uses the most advanced technologies and biological implant (PRP, Stamina cells, Ozone Therapy) and mini invasive surgery of hip head. He treats the most of orthopedic pathology for children and adults, the most of minor and major trauma, and sport injury with advanced mini invasive technique.
Affiliation: Health Biological Sciences, Abasyn University, Peshawar,
Department: Department of Health Biological Sciences
Designation: Professor
Email:Country: Pakistan
Dr. Amin Ullah Currently serving as an Assistant Professor at Allied Health Sciences, Iqra national university Peshawar, Pakistan, since February 2022. He has around 5 years of teaching and research experience. Dr. Amin specialty on profiling of circulatory microRNAs in hepatitis, liver disorders, COVID-19, cytomegalovirus, HIV, and other infectious diseases from both clinical epidemiological and molecular biology perspectives. In addition, I am conducting in vitro and in vivo/pre-clinical studies to evaluate the therapeutic potential of green-synthesized nanoparticles and drug-loaded nanoparticles against various cancer cell lines and rat models. He has supervised 45 M.Phil. research students and are mentoring Ph.D. candidates. He has more than 60+ publications of International and National in a well reputed journal with 300+ impact factor. His scientific activities are highly interdisciplinary, ranging from biotechnology and microbiology, diagnostic tools and computational biology. In addition, he has authored over 13 book chapters with renowned publishers, including Elsevier, Springer, and Taylor & Francis. Dr. Amin is currently serving as Chief Editor for two books under review. He also holds five international patents (Germany, UK). Beyond his research, he has contributed significantly to the scientific community by peer-reviewing manuscripts for more than 10 prestigious journals published by MDPI, Elsevier, Springer, and Wiley. In recognition of his academic excellence, Dr. Amin was awarded a fellowship under the HEC IRSIP program at the University of Cologne, Germany, in 2019.
Affiliation: Bioinformatics, Yunnan Normal University, Yunnan
Department: Department of Bioinformatics
Designation: Associate Professor
Email:Country: China
Chunyan Li, Ph.D., is an Associate Professor and Doctoral Supervisor, recognized as a high-level talent introduced by Yunnan Normal University, Kunming, China. She is a Senior Member of the China Computer Federation and a member of the Chinese Association for Artificial Intelligence. She received the Ph.D. degree in computer science and technology from Xiamen University, Xiamen, China, in 2022. Her primary research interests lie in intelligent computing and biomedical artificial intelligence, with a particular focus on deep learning for molecular 3D geometry, computational drug design, the development of algorithms for molecular structure representation, the construction of multi-attribute prediction models for drug discovery and out-of-distribution in the field of bioinformatics.
Affiliation: School of Materials Science and Engineering, Yeungnam University, Gyeongsan
Department: Department of School of Materials Science and Engineering
Designation: Assistant Professor
Email:Country: Republic of Korea
Abdelkarim Chaouiki has been working an assistant professor for Yeungnam University, Republic of Korea. Prior to the current affiliation, he has been granted Ph.D. diploma from Department of Chemistry at Ibn Tofail University, Morocco. Recently, his research interest has focused on development of advanced surface materials, such as corrosion engineering by organic inhibitor, architecture designing for hybrid materials, geometrical arrangement on reticular chemistry and their computational perspectives to discover the structure-properties relationship of continuum matters as a primary source.
Affiliation: Chemistry, College of Science, Taibah University, Medina
Department: Chemistry
Designation: Professor
Email:Country: Saudia Arabia
Ahmed Mohammed Abu-Dief Mohammed, Professor of Inorganic and Physical Chemistry at Chemistry Department, College of Science, Taibah University, Al-Madina Al-Mounowara, Saudi Arabia and he obtained Post doctor from Faculty of Chemistry, Oviedo University, Spain, 2015. Dr. Ahmed Mohammed Abu-Dief published more than 180 articles in international journals, 15 books and participates in more than 125 workshops and international conferences with h- index 68. Moreover, He works as a reviewer in 290 international journals and member of editorial board in more than 65 journals. Stanford University listed his name in the 2% World Research Scientist Ranking in the last five years (2020-2024). He was awarded several prizes such as State Encouragement Award, University Encouragement Award, University Research Excellence Award, Highly cited research Award, and Golden Medal for outstanding performance. He has ten granted US patents, in different areas such as nanomaterials for drug delivery, nanomaterials for electronic devices, nanomaterials for waste water treatment and design of organometallic compounds for super pharmaceutical applications.